Skip to main content
Quest Diagnostics

Updated Trial in Progress: Understanding Treatment Experience of Individuals Receiving Isatuximab Using Both Patient-reported Outcomes and Wearable Data

International Myeloma Sciety 19th Annual Meeting and Exposition

IMW2022

Los Angeles, CA, Aug 25-27, 2022

Oral presentation: Updated trial in progress: understanding treatment experience of individuals receiving isatuximab using both patient-reported outcomes and wearable data

Authors: Manasanch E, Banerjee R, Brassil K, Shah N, Cowan A

Specialties: Oncology

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA certified laboratories that provide HIPAA covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2024 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.